Hymovis 24mg 3ml 2 pieces Hexsima hyaluronic acid pre-filled syringe osteoarthritis Fidia Pharma

Hymovis 24 mg 3 ml (2 pcs.) – Innovative Hexsima technology for knee arthrosis

Hymovis 24 mg 3 ml (2 pcs.) is an innovative one Hyaluronic acid joint injection with patented Hexsima technology for intra-articular treatment of Knee osteoarthritis. The viscoelastic solution with modified hyaluronic acid offers superior biomechanical properties and long-lasting pain relief with just 2 injections – developed by Fidia Pharma.

Hymovis product features

• Active ingredient: 8 mg/ml hyaluronic acid with Hexsima technology (24 mg per 3 ml pre-filled syringe)
• 2-injection therapy: Only 2 treatments 1 week apart
• Hexsima technology: Patented modification for superior viscoelastic properties
• Sterile & pyrogen-free: CE certified according to the highest medical device standards
• Fidia Pharma quality: From one of the leading hyaluronic acid specialists
• Pre-filled syringes: 2 ready-to-use syringes for direct use

Areas of application

Hymovis is used for the symptomatic treatment of Knee osteoarthritis (gonarthrosis). Particularly suitable for:

• Mild to moderate gonarthrosis
• Patients with chronic knee pain and limited mobility
• People who prefer a shortened treatment duration (only 2 injections)
• Patients who do not wish to tolerate NSAIDs

Mechanism of action – Hexsima technology

The patented one Hexsima technology modifies hyaluronic acid for superior properties. Hymovis works through:

• Superior viscosity: Improved biomechanical properties through Hexsima modification
• Shock absorber function: Protects cartilage from mechanical stress
• Lubrication: Reduces friction for more pain-free movement
• Long-term effects: Up to 6 months of action with just 2 injections
• Anti-inflammatory: Reduces inflammatory reactions in the joint

Advantages of Hexsima technology

• Only 2 injections: Shortened treatment duration instead of 3-5 injections
• Patented innovation: Unique modification for better effectiveness
• Superior Biomechanics: Improved viscoelastic properties
• Long-lasting effect: Up to 6 months of pain relief
• Fidia Pharma Expertise: Over 40 years of experience in hyaluronic acid research

Application & dosage

Dosage: 2 injections of 3 ml each into the knee joint
Treatment regimen: 2 injections 1 week apart
Duration of action: Up to 6 months
Repeat: Repeatable after 6 months if necessary
Administration: Intra-articularly by a healthcare professional

Scope of delivery

• 2 sterile pre-filled syringes each with 3 ml Hymovis (24 mg hyaluronic acid per syringe)
• Instructions for use
• CE declaration of conformity

Storage

Store at room temperature (max. 25°C). Do not freeze. Protect from light. Note expiry date.

Manufacturer

Fidia Pharma GmbH – Leading specialist in hyaluronic acid products with over 40 years of experience in research and development of viscoelastic solutions.

This product is intended for use by healthcare professionals only. Please note the instructions for use and specialist information.